Dakshidin Corporation, Inc. (DKSC)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0001 (-20.00%)
Feb 12, 2026, 2:44 PM EST
Dakshidin Corporation Company Description
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company.
It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments.
Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007.
The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.
Dakshidin Corporation, Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Christopher Haigh |
Contact Details
Address: 2250 NW 114th Avenue Miami, Florida 33172-3652 United States | |
| Phone | 888-818-9167 |
Stock Details
| Ticker Symbol | DKSC |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Reporting Currency | USD |
| ISIN Number | US2342631015 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Christopher Robin Haigh | Chief Executive Officer and Director |
| Charles L. Nuzum Sr., CPA | Chief Financial Officer and Secretary to the Board of Directors |
| Samuel J. Butero | Chief Operating Officer |
| Robert Mack Peak | Chief Marketing Officer |